Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers
Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee
Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation
Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group
Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease
Feasibility of marrow harvesting from pediatric sibling donors without hematopoietic growth factors and allotransfusion
EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantation
Human AdV-specific T cells: persisting in vitro functionality despite lethal irradiation
Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT
A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies
Accuracy of self-reported tobacco use status among hematopoietic SCT patients
Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation
Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD
Estimation of size of cord blood inventory based on high-resolution typing of HLAs
Feasibility of umbilical cord blood transplantation with a myeloablative, reduced toxicity-conditioning regimen
Systemic lupus erythematosus complicated with thymoma and pure red cell aplasia (PCRA). CR of both complications following thymectomy and allogeneic haematopoietic SCT (HSCT), but persistence of antinuclear antibodies (ANA)
Treatment of acute mixed-cell leukemia with autologous hematopoietic SCT followed by allogeneic hematopoietic stem cell micro-transplantation
Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD
Isolated orbital relapse of multiple myeloma in a patient with severe chronic GVHD after allogeneic hematopoietic SCT
The commitment and evaluation of the quality management plan by professionals from accredited stem cell transplant centers in Spain
Peanut allergy transferred by BMT
Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma
Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT